Iglitazone free base Cas：761423-87-4
Pharmaceutical Materials 2025-03-03
Iglitazone free base, with a CAS number of 761423-87-4, is actually a misnomer as the correct compound associated with this CAS number is Ipragliflozin, not Iglitazone. Ipragliflozin is a highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor, used primarily in the treatment of type 2 diabetes.
It works by inhibiting the reabsorption of glucose in the kidney, thereby promoting glucose excretion and lowering blood glucose levels. Ipragliflozin has been shown to be effective and well-tolerated in patients with type 2 diabetes, particularly those who are receiving insulin therapy. Despite the naming confusion, Ipragliflozin (CAS 761423-87-4) remains an important therapeutic option for managing blood glucose levels in diabetic patients.
| Name | Ipragliflozin (Correct Compound for CAS 761423-87-4) |
| CAS Number | 761423-87-4 |
| Molecular Formula | C21H21FO5S |
| Molecular Weight | 404.45 g/mol |
| Appearance | White to off-white powder |
| Purity | Typically 98%-99% |
| Applications | Sodium-glucose cotransporter 2 (SGLT2) inhibitor, used in the treatment of type 2 diabetes. |
| Storage Conditions | Store in a cool, dry place away from light and moisture. |
| Safety Information | Handle with appropriate personal protective equipment. Refer to the safety data sheet for detailed information. |
,Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
